Page last updated: 2024-08-05 11:35:32
3-oxo-5alpha-steroid
A 3-oxo steroid that has alpha configuration at position 5.
ChEBI ID: 13601
Members (12)
Member | Definition | Role |
---|---|---|
5-alpha-dihydroprogesterone | A C21-steroid hormone that is 5alpha-pregnane substituted by oxo groups at positions 3 and 20. It is a metabolite of progestrone. | 5alpha-pregnane-3,20-dione |
5-dihydrocorticosterone | 5alpha-dihydrocorticosterone | |
androstane-3,17-dione, (5alpha)-isomer | The 5alpha-stereoisomer of androstane-3,17-dione. | 5alpha-androstane-3,17-dione |
cycloeucalenone | A pentacyclic triterpenoid that is 4alpha,14-dimethyl-9beta,19-cyclo-5alpha-ergost-24(28)-ene which is substituted by an oxo group at position 3. It has been isolated from several plant species including Quercus variabilis, Ammocharis coranica, Solanum cernuum and Tinospora crispa. | cycloeucalenone |
dafachronic acid | A cholestanoid that is (5alpha)-cholestan-26-oic acid in which the hydrogens at position 3 are replaced by an oxo group. | (5alpha)-3-oxocholestan-26-oic acid |
dihydrotestosterone | A 17beta-hydroxy steroid that is testosterone in which the 4,5 double bond has been reduced to a single bond with alpha-configuration at position 5. | 17beta-hydroxy-5alpha-androstan-3-one |
dihydrotestosterone glucuronide | A steroid glucosiduronic acid that is 5alpha-dihydrotestosterone having a single beta-D-glucuronic acid residue attached at position 17. | 5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide) |
dromostanolone | metholone | |
dromostanolone propionate | dromostanolone propionate | |
mestanolone | Mestanolone | |
mesterolone | mesterolone | |
stanolone benzoate | Stanolone benzoate |
Research
Studies (9,230)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 4,158 (45.05) | 18.7374 |
1990's | 1,659 (17.97) | 18.2507 |
2000's | 1,645 (17.82) | 29.6817 |
2010's | 1,397 (15.14) | 24.3611 |
2020's | 371 (4.02) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 330 (3.36%) | 5.53% |
Reviews | 443 (4.51%) | 6.00% |
Case Studies | 201 (2.05%) | 4.05% |
Observational | 12 (0.12%) | 0.25% |
Other | 8,827 (89.95%) | 84.16% |